Adverse Drug Reaction to First-Line Oral Antitubercular Drugs: An 8-Year Analysis from a Tertiary Centre in Eastern

Ratikanta Tripathy1, Pratima Singh2, Debasis Behera2

  • 1Deparment of Pharmacology, KIMS, KIIT, Bhubaneswar, Odisha, India.

Abstract

Insights

Adverse drug reactions (ADRs) are common with anti-tuberculosis (TB) treatment. Drug-induced liver injury (DILI) was the most frequent ADR reported, highlighting the need for vigilant monitoring and reporting.

Area of Science:

  • Pharmacovigilance
  • Infectious Diseases
  • Clinical Pharmacology

Background:

  • Tuberculosis (TB) treatment relies on first-line anti-tubercular drugs.
  • Fixed-dose combinations are associated with various adverse drug reactions (ADRs).
  • Common ADRs include drug-induced liver injury (DILI), myalgia, arthralgia, hearing loss, and gastrointestinal issues.

Purpose of the Study:

  • To analyze the spectrum and severity of ADRs in TB patients.
  • To specifically focus on drug-induced liver injury (DILI) as a significant ADR.

Main Methods:

  • Retrospective study conducted between 2015 and 2023.
  • Inclusion of 108 patients from a tertiary care teaching hospital.
  • Classification of ADRs using WHO systems organ classes and seriousness criteria; DILI severity graded.

Main Results:

  • A total of 126 ADRs were documented.
  • Drug-induced liver injury (DILI) was the most frequently reported ADR.
  • Vomiting and itching were also commonly reported ADRs.

Conclusions:

  • Findings aim to improve clinicians' understanding of anti-TB treatment ADRs.
  • Emphasizes the importance of patient counseling and safety prioritization.
  • Encourages active reporting of all ADRs, including mild reactions.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.8K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
828
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
1.0K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
429
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
220